Drawing for IO

USPTO serial 90031116

IO

Reviewed by CopyMark Law Group

Reg. 6376409Status 700Renewal
Filing date
Status date
Registration date
Jun 8, 2021
Examiner
GRIFFIN, JAMES
Law office
TMEG LAW OFFICE 103

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with IO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $2,144*

Plus Government fees of $1,950

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Dmitriy O. Makarov

Dmitriy O. Makarov IpHorgan Ltd.195 Arlington Heights Rd, Suite #125Buffalo Grove, IL 60089-1768United States

Goods and services

ClassDescriptionStatusFirst use
001Stem cells for research purposes; Stem cells for scientific purposes; Stem cells other than for medical or veterinary purposes; Skeletal myocytes for research purposes; Cortical neurons for research purposes; Biological human tissue for research and scientific purposes; Biological tissue cultures other than for medical or veterinary purposes; Cultures of cell media for scientific or research use; Chemical reagents for use in biotechnology, other than for medical or veterinary use; Nutritive agents for processing living cells; Semi-processed natural proteins for manufacturing food; Proteins for use in the manufacture of food products; Proteins for use in recombinant DNA technologyACTIVE—
005Pharmaceuticals in the nature of cell therapeutics for medical, therapeutic or clinical use; Genetically or otherwise modified cells for medical or clinical use; Cells which are propagated, cultivated and expanded in bioreactors for medical or clinical use; Cells for the purpose of tissue regeneration for medical, therapeutic or clinical use; Living cells for medical use; Cells for medical use; Biological preparations for medical use; Diagnostic preparations for medical and/or veterinary purposes; Cell preparations for medical use for drug screening; Cell preparations for genetic testing, screening for medical purposes or clinical use; Stem cells for medical purposes; Stem cells for veterinary purposes; Cell growth media for growing cells, tissue culture media, cytokines, antibodies, and reagents for medical, medical research or diagnostic use; Tissue culture media growth factors in the nature of cell growth, cell growth media, and nutritional supplements for in vitro culturing, development, maintenance, expansion, assay or manipulation of cells, all for medical or clinical use; Cell separation reagents for medical and clinical use; Dietary supplements; Protein supplements; nutrition supplementsACTIVE—
009Downloadable and recorded computer software and computer hardware for the separation of biological and non-biological materials; downloadable and recorded bioinformatics software for collection of information on biological materials; downloadable and recorded software for the control of laboratory robots; downloadable and recorded software program for medical, clinical, research and biomanufacturing purposes, namely, downloadable and recorded software for conducting medical and clinical research and to control laboratory manufacturing robots; Bioreactors for biomanufacturing; Bioreactors for research use; Bioreactor for cell culturing; Bioreactors for laboratory use; Downloadable and recorded computer-aided manufacturing software for the separation of biological and non-biological materials; Smart manufacturing system controls for laboratory robots and laboratory automation equipment featuring downloadable software incorporating algorithms to control laboratory robots and laboratory automation equipment; Electronic control units for laboratory robots and laboratory automation equipment featuring downloadable software incorporating algorithms to control laboratory robots and laboratory automation equipment; laboratory apparatus for magnetic cell separation, namely, apparatus for the separation of cell populations for medical or clinical useACTIVE—
029Meat; Meat substitutes; Tissue engineered meat; Synthetic meat; Cultured meat; Laboratory-grown meat; Fish, not liveACTIVE—
040Custom manufacture of biopharmaceuticals; processing of biopharmaceutical materials for others; custom manufacture of stem cells for research purposes, Stem cells for scientific purposes, Stem cells other than for medical or veterinary purposes, Skeletal myocytes for research purposes, Cortical neurons for research purposes, Biological tissue for research and scientific purposes, Biological tissue cultures other than for medical or veterinary purposes, Cultures of cell media other than for medical or veterinary use, Chemical reagents for use in biotechnology, other than for medical or veterinary use, Nutritive agents for processing living cells other than for medical use, Semi-processed natural proteins for manufacturing food, Proteins for use in the manufacture of food products, Proteins for use in recombinant DNA technology other than for medical use, cell therapeutics, Genetically or otherwise modified cells, Cells which are propagated, cultivated and expanded in bioreactors, Cells for the purpose of tissue regeneration, Living cells for medical use, Cells for medical use, Biological preparations for medical use, Diagnostic preparations for medical and/or veterinary purposes, Cell preparations for drug screening, Cell preparations for genetic testing, screening, Stem cells for medical purposes, Stem cells for veterinary purposes, Cell growth media, tissue culture media, cytokines, antibodies, and reagents for medical, medical research or diagnostic use, Tissue culture media, growth factors, growth media, serum, and nutritional supplements for in vitro culturing, development, maintenance, expansion, assay or manipulation of cells, Cell separation reagents, magnetic cell separation equipment, Dietary supplements, Protein supplements, nutrition supplements, Meat, Meat substitutes, Tissue engineered meat, Synthetic meat, Cultured meat, Laboratory-grown meat and Fish, not liveACTIVE—
042Biotechnology research; Scientific testing for others in the area of biotechnology for research, clinical, therapeutic and manufacturing purposes; Stem cell research; Synthetic biology services, namely, biological research; Stem cell biology services, namely, biological research; Scientific services for scientific, research, clinical, therapeutic and manufacturing purposes relating to the isolation and cultivation of human tissues and cells; Research and development in the field of microorganisms and cells; Research and development in relation to genetic testing, screening; Research and development in relation to drug screening; Cell separation technology services for scientific, research, clinical, therapeutic and manufacturing purposes; Cell separation research services; Consultancy relating to biotechnology; Scientific and research consultancy relating to drug screening; Scientific and research consultancy relating to genetic screening; Scientific and research consultancy relating to cell therapy; Laboratory research in the field of drug discovery, cell therapy, stem cells, microorganisms, human tissues, synthetic biology and biomanufacturing; Research on food; Research and development in the field of animal cells cultivated within bioreactors; Research in the reduction of carbon emissions; development and testing of computing methods, software algorithms and software for medical, clinical, research and biomanufacturing purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 8, 2026REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Nov 28, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 28, 2025ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Nov 28, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 28, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 28, 2025CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Nov 28, 2025COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Nov 28, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 28, 2025ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Nov 28, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 28, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 28, 2025CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Nov 28, 2025COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Dec 29, 2021COC.CORRECTION UNDER SECTION 7 - PROCESSED—
Nov 29, 2021APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jul 1, 2021ES7RTEAS SECTION 7 REQUEST RECEIVED—
Jun 8, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 21, 2021CORVREVIEW OF CORRESPONDENCE COMPLETE—
May 19, 2021APETASSIGNED TO PETITION STAFF—
Mar 23, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 23, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 4, 2021EPPATEAS POST PUBLICATION AMENDMENT RECEIVED—
Mar 3, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 17, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 17, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Feb 17, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 16, 2021ALIEASSIGNED TO LIE—
Feb 11, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 8, 2020GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 8, 2020GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 8, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 7, 2020ATRVATTORNEY REVIEW COMPLETED—
Sep 4, 2020DOCKASSIGNED TO EXAMINER—
Aug 24, 2020AMPXPRELIMINARY/VOLUNTARY AMENDMENT - ENTERED—
Aug 21, 2020ALIEASSIGNED TO LIE—
Aug 4, 2020PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Jul 30, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 4, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance